- P-ISSN 1010-0695
- E-ISSN 2288-3339
Background : Advanced-stage endometrial cancer patients show a poor prognosis because of limited success from surgery, radiotherapy or chemotherapy. Recently, the uses of complimentary and alternative medicines have gained popularity for these patients. Cases : The first case is a 46-year-old patient with FIGO stage IVb endometrial cancer who had distant metastasis on her supraclavicular LNs area; the second, a 72-year-old stage Ib patient who could not be treated with surgery or chemotherapy because of chronic heart disease and her refusal of radiation therapy due to her advanced age. They remain alive and in stable condition under a strict traditional herbal medicine regiment 41 and 52 months, respectively, after diagnosis. Conclusion : We present two cases of endometrial cancer patients who desire to be treated by traditional herbal medication with no further development.
(2001) Analysis of FIGO stage Ⅲ c endometrial cancer patients,
(2001) Prevalence of complementary and alternative medicine use in cancer patients,
(1999) Pathologic stage Ⅲ and endometrial cancer treated with adjuvant radiation therapy,
(1999) Study on the anti-metastasis and immune activity of Hangam-dan(HAD),
(2004) Effects of Cordyceps militaris extract on angiogenesis and tumor growth,
(2005) Changes of Serum VEGF, b-FGF levels and platelet counts in 100 cancer patients treated with Hangam- dan (HAD),
(2002) Clinical implications of the expression of estrogen receptor-alpha and -beta in primary and metastatic lesions of uterine endometrial cancers,
(2002.4.10) Estrogen receptor alpha mRNA variant lacking exon 5 is co-expressed with the wild-type in endometrial adenocarcinoma,
(2006.5) Anti-tumor effects of herbal medicines on endometrial carcinomas via estrogen receptor-alpha-related mechanism,